1. Apoptosis
  2. Ferroptosis
  3. FIN56

FIN56 is a specific inducer of ferroptosis. FIN56 induces ferroptosis by inducing degradation of GPX4. FIN56 also binds to and activates squalene synthase.

For research use only. We do not sell to patients.

CAS No. : 1083162-61-1

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 24 publication(s) in Google Scholar

Other Forms of FIN56:

Top Publications Citing Use of Products

    FIN56 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 26;15(1):9261.  [Abstract]

    BD-PMN was pretreated with FIN56 (1 μM and 5 μM) to activate FDFT1, for 16 hours. The expression levels of TNF, IL-6, IL-18, and IL-1β were detected by qRT-PCR (N = 4, for each group).

    FIN56 purchased from MedChemExpress. Usage Cited in: Sci Adv. 2024 Mar 29;10(13):eadk1200.  [Abstract]

    Cell viability assay of HT-1080 cells pretreated with or without AS for 1 h and then stimulated with 40 μM FIN56.

    FIN56 purchased from MedChemExpress. Usage Cited in: Sci Adv. 2024 Mar 29;10(13):eadk1200.  [Abstract]

    LDH release assay of HT-1080 cells pretreated with or without AS for 1 h and then stimulated with 40 μM FIN56.

    FIN56 purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2024 Jun 1:S0891-5849(24)00506-9.  [Abstract]

    FIN56 (20 μM). CBD represses γH2AX production and cell death caused by radiation and ferroptosis inducers. Representative live and dead cell stained by Calcein-AM/PI. Scale bar: 200 μm.

    FIN56 purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2022 Jul:187:158-170.

    FIN56. Effect of NAC and/or on Gpx4 expression and ferroptosis in MDCK cells under HG treatment. Immunofluorescence staining for Gpx4 (scale bar is 75 μm).

    FIN56 purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2022 Jul:187:158-170.

    FIN56. Effect of NAC and/or on Gpx4 expression and ferroptosis in MDCK cells under HG treatment. Representative blots of CD71 and Slc7a11.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    FIN56 is a specific inducer of ferroptosis. FIN56 induces ferroptosis by inducing degradation of GPX4. FIN56 also binds to and activates squalene synthase[1].

    Cellular Effect
    Cell Line Type Value Description References
    LN-229 IC50
    4.2 μM
    Compound: 28; FIN56
    Induction of ferroptosis in human LN-229 cells assessed as GPX4 degradation
    Induction of ferroptosis in human LN-229 cells assessed as GPX4 degradation
    [PMID: 36332549]
    U-118-MG IC50
    2.6 μM
    Compound: 28; FIN56
    Induction of ferroptosis in human U-118-MG cells assessed as GPX4 degradation
    Induction of ferroptosis in human U-118-MG cells assessed as GPX4 degradation
    [PMID: 36332549]
    In Vitro

    FIN56 (5 μM) can trigger ferroptosis by inhibition of glutathione peroxidase 4 (GPX4)[2].
    FIN56 (5 μM, 10 hours) depletes GPX4 protein in HT-1080 cells[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[2]

    Cell Line: TP53+/+ and TP53-/- HCT116 cells
    Concentration: 5 μM
    Incubation Time:
    Result: Triggered ferroptosis.

    Western Blot Analysis[3]

    Cell Line: HT-1080 cells
    Concentration: 5 μM
    Incubation Time: 10 hours
    Result: Caused a large decrease in the abundance of GPX4 at the protein level.
    Molecular Weight

    517.66

    Formula

    C25H31N3O5S2

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=S(C1=CC(/C2=N\O)=C(C3=C2C=C(S(=O)(NC4CCCCC4)=O)C=C3)C=C1)(NC5CCCCC5)=O

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 100 mg/mL (193.18 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.9318 mL 9.6588 mL 19.3177 mL
    5 mM 0.3864 mL 1.9318 mL 3.8635 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.5 mg/mL (4.83 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.5 mg/mL (4.83 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 98.03%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.9318 mL 9.6588 mL 19.3177 mL 48.2942 mL
    5 mM 0.3864 mL 1.9318 mL 3.8635 mL 9.6588 mL
    10 mM 0.1932 mL 0.9659 mL 1.9318 mL 4.8294 mL
    15 mM 0.1288 mL 0.6439 mL 1.2878 mL 3.2196 mL
    20 mM 0.0966 mL 0.4829 mL 0.9659 mL 2.4147 mL
    25 mM 0.0773 mL 0.3864 mL 0.7727 mL 1.9318 mL
    30 mM 0.0644 mL 0.3220 mL 0.6439 mL 1.6098 mL
    40 mM 0.0483 mL 0.2415 mL 0.4829 mL 1.2074 mL
    50 mM 0.0386 mL 0.1932 mL 0.3864 mL 0.9659 mL
    60 mM 0.0322 mL 0.1610 mL 0.3220 mL 0.8049 mL
    80 mM 0.0241 mL 0.1207 mL 0.2415 mL 0.6037 mL
    100 mM 0.0193 mL 0.0966 mL 0.1932 mL 0.4829 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    FIN56 Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    FIN56
    Cat. No.:
    HY-103087
    Quantity:
    MCE Japan Authorized Agent: